tiprankstipranks
Grifols SA (DE:G0FB)
FRANKFURT:G0FB
Germany Market

Grifols SA (G0FB) Stock Forecast & Price Target

15 Followers
See the Price Targets and Ratings of:

G0FB Analyst Ratings

Currently, no data available
Based on NaN analysts giving stock ratings to
Grifols
SA
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

G0FB Stock 12 Month Forecast

There Are No Analyst Ratings for DE:G0FB In The Last 3 Months.
Highest Price TargetAverage Price TargetLowest Price Target
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

G0FB Financial Forecast

G0FB Earnings Forecast

Next quarter’s earnings estimate for G0FB is €0.25 with a range of €0.25 to €0.25. The previous quarter’s EPS was €0.23. G0FB beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 58.33% of the time in the same period. In the last calendar year G0FB has Performed in-line its overall industry.
Next quarter’s earnings estimate for G0FB is €0.25 with a range of €0.25 to €0.25. The previous quarter’s EPS was €0.23. G0FB beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 58.33% of the time in the same period. In the last calendar year G0FB has Performed in-line its overall industry.

G0FB Sales Forecast

Next quarter’s sales forecast for G0FB is €1.95B with a range of €1.95B to €1.95B. The previous quarter’s sales results were €1.89B. G0FB beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 66.67% of the time in the same period. In the last calendar year G0FB has Performed in-line its overall industry.
Next quarter’s sales forecast for G0FB is €1.95B with a range of €1.95B to €1.95B. The previous quarter’s sales results were €1.89B. G0FB beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 66.67% of the time in the same period. In the last calendar year G0FB has Performed in-line its overall industry.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
J.P. Morgan
€8.91€8.65
Hold
27.25%
Upside
Reiterated
12/08/25
Grifols price target lowered to $10 from $10.30 at JPMorganGrifols price target lowered to $10 from $10.30 at JPMorgan
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
J.P. Morgan
€8.91€8.65
Hold
27.25%
Upside
Reiterated
12/08/25
Grifols price target lowered to $10 from $10.30 at JPMorganGrifols price target lowered to $10 from $10.30 at JPMorgan
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
AVBPArriVent BioPharma, Inc.
BTSGBrightSpring Health Services, Inc.
ZURAZura Bio
TNYATenaya Therapeutics
CNTXContext Therapeutics
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Grifols SA

3 Months
Success Rate
1/3 ratings generated profit
33%
Average Return
-2.23%
Copying Google Drug Manufacturers - General's trades and holding each position for 3 Months would result in 33.33% of your transactions generating a profit, with an average return of -2.23% per trade.
1 Year
Success Rate
1/3 ratings generated profit
33%
Average Return
-5.83%
Copying Google Drug Manufacturers - General's trades and holding each position for 1 Year would result in 33.33% of your transactions generating a profit, with an average return of -5.83% per trade.
2 Years
Success Rate
1/3 ratings generated profit
33%
Average Return
-5.83%
Copying Google Drug Manufacturers - General's trades and holding each position for 2 Years would result in 33.33% of your transactions generating a profit, with an average return of -5.83% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

G0FB Analyst Recommendation Trends

Rating
Apr 26
May 26
Jun 26
Jul 26
Aug 26
Strong Buy
0
0
0
0
0
Buy
0
0
0
0
0
Hold
0
0
0
0
0
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
0
0
0
0
0
In the current month, G0FB has received 0 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. G0FB average Analyst price target in the past 3 months is .
Each month's total comprises the sum of three months' worth of ratings.

G0FB Stock Forecast FAQ

What is DE:G0FB’s average 12-month price target, according to analysts?
Currently, no data Available
What is DE:G0FB’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for DE:G0FB, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
    How can I follow the stock ratings of top Wall Street analysts?
    Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
      Is Grifols SA a Buy, Sell or Hold?
      Currently, no data Available
      What is Grifols SA’s share price target?
      Currently, no data Available
      What do analysts say about Grifols SA?
      Not enough analysts have published a price target to provide an average price target.
      How can I buy shares of Grifols SA?
      To buy shares of DE:G0FB, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.